The co-founder of IRB Barcelona at PCB and president of its External Advisory Board received together with Manel Esteller and Josep Baselga, the Catalonia International Award presented by the Government of Catalonia for their revolutionary work in oncology, which has contributed to the advancement of biomedicine at the international level.
The Knowledge Transfer program in psoriasis between the academia and the industry developed by the Translational Immunology Group of the Department of Physiology and Immunology at the University of Barcelona (UB)- based at the Barcelona Science Park (PCB)– has been recognized with the Antoni Caparrós Award, one of the five awards that the UB Board of Trustees and the Bosch i Gimpera Foundation (FBG) granted this last Wednesday.
This Thursday, March 25, the Barcelona Science Park has awarded the prizes for the 17th edition of Batx2Lab, the research project tutoring programme for upper secondary school students. This year,…
BHV Partners, the first venture builder in the southern European health sector, has moved its headquarters to the Barcelona Science Park, and closes an investment round, raising half a million euros. In just over a year of history, the company, also based in Silicon Valley (San Francisco), has established itself as a leading driver in the biomedical innovation and entrepreneurship scene; it has three startups in its portfolio; has established several consulting contracts with companies and research centers, and is initiating an ambitious phase of national and international expansion.
Moirai Biodesign, a biotech start-up based in the Barcelona Science Park, has developed a prototype ‘kit’ based on biosensors that analyzes a blood sample and identifiesthe most important sepsis-causing pathogens and their associated antibiotic resistances, at the point of care and directly from the patient’s blood, in just three hours, a process that usually requires up to 5 days of analysis in the laboratory. The company has just received a €75,000 grant through the Startup Capital financing line from ACCIÓ to to set about the activities derived from the execution of the initial business plan. Its objective is to market this device in hospitals, once the validation phase is completed.The kit will allow identification
A study carried out by a team of researchers from Eugin’s Basic Research Laboratory, headquartered in the Barcelona Science Park, published in the journal Human Reproduction, has, for the first time, analysed the eggs of women diagnosed with Covid-19 detecting no viral material within them. The findings, globally considered ground-breaking and pioneering in the field of assisted reproduction, supports the notion that there would be no vertical transmission of the infection from mother to child via their eggs.
Oncoheroes Bioscience –a Boston based biotech with the European subsidiary at the Barcelona Science Park– focused on advancing new therapies for childhood cancer, is pleased to announce that the United States Food and Drug Administration (FDA) has granted the designation of rare pediatric disease to volasertib, an investigational treatment for rhabdomyosarcoma.
A spin-off by the University of Barcelona Enlighting Technologies, based in the Barcelona Science Park, has created Kumux to launch a 2.0 simulation spectrum software which, through patented algorithms, creates a differential light with beneficial effects for health for both people and plant growth. It is an smart lighting solution –autonomous and based on LED technology–, compatible with different systems and designed so that it can be integrated into any luminaire or control platform.
An analysis of the environment in which the embryos that become implanted in the uterus develop reveals a lower number of senescent (aged) cells than those that are not successful. This is the result of a study presented yesterday at ESHRE 2020, which has been led by researchers from Eugin’s Basic Research Laboratory, headquartered in the Barcelona Science Park. The group also submited at the congress another work –carried out with the Center for Genomic Regulation (CRG) and the collaboration of the National Center for Genomic Analysis (CNAG)– which reveals that the quality of the eggs can lie in the networks that create their genes.
Thanks to its global network of collaborators, the DTI Foundation –based in the Barcelona Science Park– has created the International Database on Organ Donation and Transplantation COVID-19 (IDOTCOVID) with the collaboration of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) –Hospital Clínic de Barcelona and with the endorsement of the IRODaT registry and the LIDOBS observatory. The objective of this initiative is to provide clinical evidence in the scientific community towards the establishment of treatment and management protocols for patients infected with SARS-CoV2.
